CD90+ UCCs do not exhibit a distinct stem cell-like phenotype. Original flow cytometry data for abundance of CD90+ cells corresponding to the summarized data in Fig. 3. a) CD90+ fraction in unsorted (top), CD90 magnetically enriched (middle, indicated by arrow) and CD90 depleted (bottom) cell cultures. b) Following reculturing for 7–8 population doublings the number of CD90+ cells was determined again in the respective fractions. (TIF 6628 kb
Contains fulltext : 89169schalken.pdf (publisher's version ) (Closed access)BACKGR...
Showing microarray analysis and identification of CDCP1+CD90+CD66– HpSCs, related to Fig. 1. Heatmap...
Figure S1. Expression of CSC-associated genes up-regulated in AB12 and RN5 cells after cisplatin tre...
Endogenous abundance of subpopulations from differentiation states and subsequent to short-term cisp...
Activation of WNT-signalling may contribute to survival of UCCs upon long-term cisplatin treatment. ...
Primer sequences for quantitative real-time-PCR. Sequences of primers (5′-3′) used for quantitative ...
SP differentiation assay for evaluation of CSC enrichment in TOV21G and SKOV3. A & B. Quantification...
Background: Tumour heterogeneity and resistance to systemic treatment in urothelial carcinoma (UC) m...
Flow cytometric analysis of the pluripotent markers (TRA-1-60, SSEA4), hematopoietic markers (CD34, ...
Showing characteristics of putative CDCP1+CD90+CD66â HpSCs, related to Fig. 1. Immunophenotype of...
Applied strategy to determine cell cycle phases of subpopulations by flow cytometry. Flow cytometric...
Figure S2. Additional data on flow cytometry. (A) Expression of CD44, CD73, and CD90 in induced plur...
Figure S1. MSCs increase stem marker expression of PCa. A. Western blot analysis of stem marker (CD1...
Phenotype plasticity rather than repopulation from CD90/CK14+ cancer stem cells leads to cisplatin r...
Immunophenotyping of adipose tissue-derived mesenchymal stem cells by flow cytometry. a Flow Gate; b...
Contains fulltext : 89169schalken.pdf (publisher's version ) (Closed access)BACKGR...
Showing microarray analysis and identification of CDCP1+CD90+CD66– HpSCs, related to Fig. 1. Heatmap...
Figure S1. Expression of CSC-associated genes up-regulated in AB12 and RN5 cells after cisplatin tre...
Endogenous abundance of subpopulations from differentiation states and subsequent to short-term cisp...
Activation of WNT-signalling may contribute to survival of UCCs upon long-term cisplatin treatment. ...
Primer sequences for quantitative real-time-PCR. Sequences of primers (5′-3′) used for quantitative ...
SP differentiation assay for evaluation of CSC enrichment in TOV21G and SKOV3. A & B. Quantification...
Background: Tumour heterogeneity and resistance to systemic treatment in urothelial carcinoma (UC) m...
Flow cytometric analysis of the pluripotent markers (TRA-1-60, SSEA4), hematopoietic markers (CD34, ...
Showing characteristics of putative CDCP1+CD90+CD66â HpSCs, related to Fig. 1. Immunophenotype of...
Applied strategy to determine cell cycle phases of subpopulations by flow cytometry. Flow cytometric...
Figure S2. Additional data on flow cytometry. (A) Expression of CD44, CD73, and CD90 in induced plur...
Figure S1. MSCs increase stem marker expression of PCa. A. Western blot analysis of stem marker (CD1...
Phenotype plasticity rather than repopulation from CD90/CK14+ cancer stem cells leads to cisplatin r...
Immunophenotyping of adipose tissue-derived mesenchymal stem cells by flow cytometry. a Flow Gate; b...
Contains fulltext : 89169schalken.pdf (publisher's version ) (Closed access)BACKGR...
Showing microarray analysis and identification of CDCP1+CD90+CD66– HpSCs, related to Fig. 1. Heatmap...
Figure S1. Expression of CSC-associated genes up-regulated in AB12 and RN5 cells after cisplatin tre...